Michaela Blundell

454 total citations
6 papers, 300 citations indexed

About

Michaela Blundell is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Michaela Blundell has authored 6 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Molecular Biology. Recurrent topics in Michaela Blundell's work include Meta-analysis and systematic reviews (1 paper), Ethics in Clinical Research (1 paper) and Viral-associated cancers and disorders (1 paper). Michaela Blundell is often cited by papers focused on Meta-analysis and systematic reviews (1 paper), Ethics in Clinical Research (1 paper) and Viral-associated cancers and disorders (1 paper). Michaela Blundell collaborates with scholars based in United Kingdom, Australia and United States. Michaela Blundell's co-authors include Carrol Gamble, Lynne Cresswell, Paula Williamson, Kerry Dwan, Douglas G. Altman, A Bagust, Angela Boland, Y Dündar, J Oyee and Juliet Hockenhull and has published in prestigious journals such as Cochrane Database of Systematic Reviews, PharmacoEconomics and Trials.

In The Last Decade

Michaela Blundell

6 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Blundell United Kingdom 5 127 83 79 44 39 6 300
Julie Rouette Canada 11 15 0.1× 50 0.6× 41 0.5× 71 1.6× 59 1.5× 20 319
Jules T. Mitchel United States 10 55 0.4× 71 0.9× 103 1.3× 66 1.5× 28 0.7× 16 354
Caleb Scheckel United States 9 68 0.5× 43 0.5× 61 0.8× 26 0.6× 45 1.2× 25 233
Gisela Schott Germany 9 31 0.2× 93 1.1× 158 2.0× 47 1.1× 13 0.3× 27 399
Gabriel Tremblay United States 12 10 0.1× 56 0.7× 48 0.6× 107 2.4× 40 1.0× 84 425
Peter Dutton United Kingdom 7 45 0.4× 26 0.3× 32 0.4× 42 1.0× 55 1.4× 14 200
Margaret M. Farrell United States 10 15 0.1× 51 0.6× 104 1.3× 157 3.6× 15 0.4× 15 612
Jennifer M. Duff United States 8 28 0.2× 14 0.2× 76 1.0× 88 2.0× 8 0.2× 22 314
Annie Hung United States 8 20 0.2× 13 0.2× 29 0.4× 124 2.8× 68 1.7× 32 335
Sally Worsley United Kingdom 13 18 0.1× 57 0.7× 44 0.6× 88 2.0× 17 0.4× 24 548

Countries citing papers authored by Michaela Blundell

Since Specialization
Citations

This map shows the geographic impact of Michaela Blundell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Blundell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Blundell more than expected).

Fields of papers citing papers by Michaela Blundell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Blundell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Blundell. The network helps show where Michaela Blundell may publish in the future.

Co-authorship network of co-authors of Michaela Blundell

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Blundell. A scholar is included among the top collaborators of Michaela Blundell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Blundell. Michaela Blundell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Jenkinson, Michael D., Carrol Gamble, John C. Hartley, et al.. (2014). The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol. Trials. 15(1). 4–4. 39 indexed citations
2.
Greenhalgh, J, A Bagust, Angela Boland, et al.. (2013). Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin’s Lymphoma. PharmacoEconomics. 31(5). 403–413. 24 indexed citations
3.
Beale, Sophie, Rumona Dickson, A Bagust, et al.. (2013). Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal. PharmacoEconomics. 31(12). 1121–1129. 16 indexed citations
4.
Dickson, Rumona, A Bagust, Angela Boland, et al.. (2011). Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy. PharmacoEconomics. 29(12). 1051–1062. 40 indexed citations
5.
Dwan, Kerry, Douglas G. Altman, Lynne Cresswell, et al.. (2011). Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database of Systematic Reviews. 2011(1). MR000031–MR000031. 179 indexed citations
6.
Fleeman, Nigel, A Bagust, Angela Boland, et al.. (2011). Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor positive breast cancr which over-expresses HER2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026